
Algarithm debuts rebrand, sets bar for 'fish-free' marketing
In an era where transparency is top of mind for many consumers, Algarithm says brands must carefully consider where their fish alternative ingredients come from.

In an era where transparency is top of mind for many consumers, Algarithm says brands must carefully consider where their fish alternative ingredients come from.

Ingenious Ingredients (Ing2) has announced it has achieved self-affirmed GRAS (generally recognized as safe) status for its Enfinity-branded paraxanthine ingredient for use in food and beverages.

A paper that concluded that DNA barcoding techniques were more cost-effective than traditional practices for identification of vegetation species has been retracted after the lead researcher – Dr Steven Newmaster – failed to respond to questions about...

The ingredient is a combination of extracts of tamarind seed (Tamarindus indica) and turmeric (Curcuma longa). The new use patent claims a synergistic action for these two constituents.

The first pilot clinical study to investigate Biobran MGN-3’s efficacy in preventing respiratory viral infections has yielded “encouraging results”.

Flavor and fragrance company Givaudan has opened the Givaudan Nordic Experience Centre in Malmö, Sweden.

Consumer trends, technological advancements and business strategies are causing the pharma and nutra markets to merge and this opens opportunities for the players in both industries to cater to consumers looking for the ultimate wellness solutions.

Japanese confectionery company Ezaki Glico recently launched its Almond Koka brand in China and in just two months has become the top selling almond milk product on Tmall.

Japan has urged all local food and beverage brands to ensure that processes are in place to transition to new origin of raw material rules, in order to keep operations running smoothly and avoid ‘disturbances’.

Kusum Healthcare, a pharmaceutical company based in India, has received approval from the Drugs Controller General of India (DCGI) for its wholly-synthesized vitamin C and zinc supplement.

A meta-analysis of 13 clinical trials on more than 500,000 COVID-19 patients revealed no significant association between vitamin D supplementation and improved clinical outcomes based on current evidence.

The new CEO of Australia's Melrose Health Group has underlined his plans for the firm, with innovation, sustainability and exports set to underpin his growth strategy.